SCHEMBL20169615

SCHEMBL20169615

O=S(=O)(c1ccc(NCCNCCO)nc1)N1CCCC1c1ccccc1-c1cncn1CCc1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 4/20 0.34
TSHR P16473 2/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
TRPA1 O75762 1/20 0.34
CASP3 P42574 2/20 0.34
CASP7 P55210 2/20 0.34
CYP11B2 P19099 1/20 0.34
GAA P10253 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
IDO1 P14902 1/20 0.32
CYP2B6 P20813 1/20 0.32
FKBP1A P62942 1/20 0.32
HTT P42858 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16718960 0.87 IDO1 (0.39) ALDH1A1KDM4ELMNATSHRTP53
SCHEMBL16718984 0.83 GAA (0.44) KDM4ELMNATRPA1CYP11B2GAA
SCHEMBL18128803 0.83 GAA (0.44) KDM4ELMNATRPA1CYP11B2GAA
SCHEMBL18128802 0.82 TRPA1 (0.38) ALDH1A1KDM4ELMNATP53MAPT
SCHEMBL16731030 0.82 TRPA1 (0.38) ALDH1A1KDM4ELMNATP53MAPT
SCHEMBL16731956 0.82 LMNA (0.36) KDM4ELMNATSHRTP53MAPT
SCHEMBL18128806 0.82 LMNA (0.36) KDM4ELMNATSHRTP53MAPT
SCHEMBL16719035 0.81 ALDH1A1 (0.39) ALDH1A1KDM4ELMNATSHRTRPA1
SCHEMBL16720941 0.79 ALDH1A1 (0.42) ALDH1A1LMNAMAPTTRPA1CASP3
SCHEMBL16719057 0.78 CYP11B2 (0.41) TRPA1CYP11B2CYP3A4CYP2D6IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9975888-B2 Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug MERCK SHARP & DOHME CORP. (US) 2018-05-22 US disclosed